tripelennamine has been researched along with Hypoxia in 2 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Hypoxia: Sub-optimal OXYGEN levels in the ambient air of living organisms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manohar, M | 1 |
| Goetz, TE | 1 |
| Humphrey, S | 1 |
| Depuy, T | 1 |
| Pelletier, CL | 1 |
| Shepherd, JT | 1 |
2 other studies available for tripelennamine and Hypoxia
| Article | Year |
|---|---|
H1-receptor antagonist, tripelennamine, does not affect arterial hypoxemia in exercising Thoroughbreds.
Topics: Animals; Arteries; Body Temperature; Carbon Dioxide; Endoscopy; Female; Histamine H1 Antagonists; Ho | 2002 |
Venous responses to stimulation of carotid chemoreceptors by hypoxia and hypercapnia.
Topics: Animals; Atropine; Blood Pressure; Carbon Dioxide; Carotid Sinus; Chemoreceptor Cells; Chloralose; D | 1972 |